Literature DB >> 26679867

Interaction of Hereditary Thrombophilia and Traditional Cardiovascular Risk Factors on the Risk of Arterial Thromboembolism: Pooled Analysis of Four Family Cohort Studies.

Bakhtawar K Mahmoodi1, Nic J G M Veeger2, Saskia Middeldorp2, Willem M Lijfering2, Jan-Leendert P Brouwer2, Jur Ten Berg2, Karly Hamulyák2, Karina Meijer2.   

Abstract

BACKGROUND: Hereditary thrombophilia is associated with a slightly increased risk of arterial thromboembolism (ATE). Whether hereditary thrombophilia interacts with traditional cardiovascular risk factors on the risk of ATE has yet to be established. METHODS AND
RESULTS: A total of 1891 individuals belonging to 4 family cohorts from the Netherlands were included in the analyses. Five hereditary thrombophilic defects, including factor V Leiden, prothrombin G20210A defect, and deficiencies of the natural anticoagulants (ie, antithrombin, protein C, and protein S), were assessed, and data on risk factors and previous ATE were collected. Thrombophilia was associated with elevated risk of ATE (hazard ratio =1.74, 95% confidence interval, 1.18-2.58; P=0.005). Overall, the association of thrombophilia with ATE tended to be stronger in the presence of traditional cardiovascular risk factors, especially the synergistic effect of thrombophilia with diabetes mellitus was striking (hazard ratio of thrombophilia-ATE association was 1.41 in nondiabetics versus 8.11 in diabetics). Moreover, the association of thrombophilia with ATE tended to be stronger in females and before the age of 55 years as compared with males and individuals >55 years of age, respectively.
CONCLUSIONS: Thrombophilia is associated with ATE. This association may be stronger in the presence of traditional cardiovascular risk factors in particular in individuals with diabetes mellitus. Future studies on thrombophilia-ATE risk should focus on high-risk populations with high prevalence of traditional cardiovascular risk factors.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  arterial thrombosis; cardiovascular disease; epidemiology; factor V Leiden; hereditary thrombophilia; protein C deficiency; protein S deficiency; prothrombin G20210A

Mesh:

Substances:

Year:  2015        PMID: 26679867     DOI: 10.1161/CIRCGENETICS.115.001211

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  7 in total

1.  In-stent thrombosis after carotid artery stenting in a patient with protein C deficiency.

Authors:  Yuichirou Iwamoto; Takaya Kitano; Shunji Matsubara; Masaaki Uno; Yoshiki Yagita
Journal:  Neurol Sci       Date:  2018-08-25       Impact factor: 3.307

2.  Protein S Deficiency and Arterial Thromboembolism: A Case Report and Review of the Literature.

Authors:  Amber Fearon; Paige Pearcy; Subramanian Venkataraman; Prabodh Shah
Journal:  J Hematol (Brossard)       Date:  2019-03-30

3.  Protein C and protein S deficiencies may be related to survival among hemodialysis patients.

Authors:  Mayuri Ichinose; Naru Sasagawa; Tetsuo Chiba; Katsuhide Toyama; Yuzo Kayamori; Dongchon Kang
Journal:  BMC Nephrol       Date:  2019-05-28       Impact factor: 2.388

Review 4.  Anticoagulant SERPINs: Endogenous Regulators of Hemostasis and Thrombosis.

Authors:  Steven P Grover; Nigel Mackman
Journal:  Front Cardiovasc Med       Date:  2022-05-03

5.  Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data.

Authors:  Lars Wallentin; Folkert W Asselbergs; Riyaz S Patel; Bakhtawar K Mahmoodi; Vinicius Tragante; Marcus E Kleber; Michael V Holmes; Amand F Schmidt; Raymond O McCubrey; Laurence J Howe; Kenan Direk; Hooman Allayee; Ekaterina V Baranova; Peter S Braund; Graciela E Delgado; Niclas Eriksson; Crystel M Gijsberts; Yan Gong; Jaana Hartiala; Mahyar Heydarpour; Gerard Pasterkamp; Salma Kotti; Pekka Kuukasjärvi; Petra A Lenzini; Daniel Levin; Leo-Pekka Lyytikäinen; Jochen D Muehlschlegel; Christopher P Nelson; Kjell Nikus; Anna P Pilbrow; W H Wilson Tang; Sander W van der Laan; Jessica van Setten; Ragnar O Vilmundarson; John Deanfield; Panos Deloukas; Frank Dudbridge; Stefan James; Ify R Mordi; Andrej Teren; Thomas O Bergmeijer; Simon C Body; Michiel Bots; Ralph Burkhardt; Rhonda M Cooper-DeHoff; Sharon Cresci; Nicolas Danchin; Robert N Doughty; Diederick E Grobbee; Emil Hagström; Stanley L Hazen; Claes Held; Imo E Hoefer; G Kees Hovingh; Julie A Johnson; Marcin P Kaczor; Mika Kähönen; Olaf H Klungel; Jari O Laurikka; Terho Lehtimäki; Anke H Maitland-van der Zee; Ruth McPherson; Colin N Palmer; Adriaan O Kraaijeveld; Carl J Pepine; Marek Sanak; Naveed Sattar; Markus Scholz; Tabassome Simon; John A Spertus; Alexandre F R Stewart; Wojciech Szczeklik; Joachim Thiery; Frank L J Visseren; Johannes Waltenberger; A Mark Richards; Chim C Lang; Vicky A Cameron; Axel Åkerblom; Guillaume Pare; Winfried März; Nilesh J Samani; Aroon D Hingorani; Jurriën M Ten Berg
Journal:  Circulation       Date:  2020-07-13       Impact factor: 29.690

6.  The risk of arterial thrombosis in carriers of natural coagulation inhibitors: a prospective family cohort study.

Authors:  Daniela Tormene; Franco Noventa; Elena Campello; Sabrina Gavasso; Michelangelo Marobin; Giacomo Turatti; Paolo Prandoni; Paolo Simioni
Journal:  Intern Emerg Med       Date:  2021-02-22       Impact factor: 3.397

7.  Myocardial infarction, prothrombotic genotypes, and venous thrombosis risk: The Tromsø Study.

Authors:  Joakim K Sejrup; Vania M Morelli; Maja-Lisa Løchen; Inger Njølstad; Ellisiv B Mathiesen; Tom Wilsgaard; John-Bjarne Hansen; Sigrid K Brækkan
Journal:  Res Pract Thromb Haemost       Date:  2020-01-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.